- Research article
- Open Access
- Open Peer Review
General practitioners can increase participation in cervical cancer screening – a model program in Hungary
© The Author(s). 2018
- Received: 20 July 2017
- Accepted: 1 May 2018
- Published: 19 May 2018
Cervical cancer is a preventable disease. Unfortunately, its mortality is high in Hungary: 9.2 deaths /100000 women/year in 2015. The Hungarian organized, nationwide cervical screening program was launched in 2003, but it could improve the coverage rate of cervical cancer screening only by a few percentage points. The vast majority of women still uses opportunistic screening and the organized screening program had little impact on participation by women who never or rarely consult their gynecologists. We assessed whether involving general practitioners in the cervical cancer screening process would increase participation.
The study consisted of two parts: 1. A questionnaire-based health survey was conducted using a representative sample of women aged 25 to 65 years from 11 Hungarian counties, in which we studied where women obtained information about cervical cancer screening. 2. Additionally, a model program and its evaluation were implemented in the practices of general practitioners in one of the 11 counties (Zala county). In this program, general practitioners were informed of their patients’ participation in the cervical cancer screening program, and they motivated those who refused the invitation.
Questionnaire-based health survey: A total of 74% (95% confidence interval (CI): 70–77%) of the target population had a screening examination within the previous 3 years. The majority (58, 95% CI: 54–62%) of the target population did not ask for information about cervical cancer screening at all. Only 21% (95% CI: 17–26%) consulted their general practitioners about cancer screening. Evaluation of the model program: the general practitioners effectively motivated 24 out of 88 women (27, 95% CI: 18–38%) who initially refused to participate in the screening program.
The majority of Hungarian women are not informed about cervical cancer screening beyond the invitation letter. General practitioners could play a more important role in mobilizing the population to utilize preventive services. The involvement of general practitioners in the organization of the cervical cancer screening program could increase the participation of those women who generally refuse the services.
- Cervical cancer screening
- General practitioner
- Health communication
- Health behavior
As general practitioners provide health service closest to the population, they are respected, trustworthy members of the local community and can have a key role in health communication, including mobilization of the population to participate in screening programs .
The aim of the study
The aim of our study was to assess where women obtain information about cervical cancer screening and to test whether the involvement of general practitioners in the cervical cancer screening program process could increase the participation rate.
This study was performed within the framework of the General Practitioners’ Morbidity Sentinel Station Program (GPMSSP). The GPMSSP is the first representative chronic disease morbidity monitoring program in Hungary . More than 200 general practitioners from 11 counties report the occurrence of non-communicable diseases with major public health importance via a quality managed system. In addition to continuous monitoring, the program provides a research framework for epidemiological and health services research.
A questionnaire-based health survey in a representative group of 25- to 54-year-old women belonging to the practices of general practitioners participating in the GPMSSP
Screening model program and its evaluation: involvement of general practitioners in the cervical cancer screening program process in Zala county.
Out of the 200 GPs who participated in GPMSSP 96 volunteered to participate in this study. In these practices 59,730 women aged 25–65 years were registered. In the first step of selecting the study population we defined the necessary sample size by county on the basis of the size of the female population aged 25–65 years in the target population (Baranya, Bács-Kiskun, Borsod-Abaúj-Zemplén, Győr-Moson-Sopron, Hajdú-Bihar, Heves, Jász-Nagykun-Szolnok, Komárom-Esztergom, Nógrád, Szabolcs-Szatmár-Bereg and Zala). In the second stage we set the necessary sample size for each general practice taking into account the number of women aged 25–65 years registered in the GP practices participating in the GPMSSP. The final size of the random sample was 1306 persons. Women living in Zala county were not included in this process.
In the power calculations of the evaluation of the model program the minimum detectable success rate was 20% with ±10% uncertainty. We planned the sample size in such a way, that if indeed this minimum effect is achieved then the lower boundary of the 95% confidence interval of the effect estimate would not include 10%. We assumed at least 45% participation in the survey, 40% participation rate in the intervention study, 80% coverage of the cytological test among the participants of the survey in Zala county who would consent to participate in the intervention pilot. This resulted in a necessary sample size of 1806 in Zala county. To be on the safe size, 2000 persons were involved in the survey in Zala county. The sub-sample of the intervention model program in Zala county was selected from women aged 25–65 years registered at the practices of the GPs participating in the model program.
A questionnaire containing questions regarding demographic and socioeconomic factors, health status, lifestyle (including physical activity, diet, smoking and sexual activity), knowledge about cervical cancer, utilization of gynecological services, participation in the cervical cancer screening program, and the source and content of information obtained about the screening program was developed [Additional file 1]. The questionnaire was tested in focus groups and was further developed before application in our study. It took approximately 25 min to complete the questionnaire. The questionnaires, along with letters containing instructions, were sent to all participants through their general practitioners to be answered anonymously. Participants were asked to send back the questionnaire by mail. We have previously reported the determinants of participation in a screening program and the major causes of refusal . In Zala county, women were additionally asked to provide written consent to participation in the model program. If they consented, then they also agreed that their personal data could be used to contact them, to track their data in the registries of the cytology labs in the county, and to inform their general practitioners about their participation in the cervical cancer screening program.
Intervention model program
We selected all participating women from Zala county who had not taken part in cervical cancer screening within 3 years prior to the survey but were willing to participate in the intervention model program (Fig. 2.). Their general practitioners were informed, and the general practitioners, in collaboration with the county screening organizing officer, sent them an invitation to the screening together with an information leaflet. The women’s participation in the screening program was monitored by the registries of the cytological laboratories in the county, which all agreed to participate in the study.
General practitioners sent information letters to women to be involved in this part of the study with an invitation to screening and enclosed a leaflet about some useful information how to prevent cervical cancer. Each of the 88 women received the same letter but each information letter was signed by the respective general practitioner.
After that, the general practitioners got reports weekly about who had taken part in the screening from the coordinator of Zala county, who received this information from the cytological labs.
Six weeks after sending the letters, the general practitioners tried to reach those women who had not taken part in the screening but at that time in person or by phone. The general practitioner tried to motivate and persuade them to cooperate and to participate in the screening program.
The participation in screening was observed for a further 4 weeks based on the reports of the cytological labs. The screening model program was terminated 4 weeks after the last call or personal invitation.
We estimated the frequencies of different characteristics in the target population by weighting for the age distribution of the counties to correct for refusal. The survey-analysis module of the statistical package STATA was used for the analysis .
Survey about obtaining information about the cervical cancer screening program in the 11 counties
Demographic characteristics of the target population
95% Confidence interval (CI)
secondary education without final examination
secondary education with final examination
post-secondary education without diploma
college or university degree
Proportion of women obtaining information about cervical cancer screening from different sources
95% Confidence interval (CI)
Leaflet found in the consultation-room
Human papilloma virus outpatient service settings
The type of information women obtained about cervical cancer screening
Answersa mentioned (%)
95% Confidence interval (CI)
Can screening reveal all early changes?
When do I receive the result of the screening?
How often do I have to attend the screening?
What happens if the result is unfavorable?
What does an unfavorable result mean?
How and who will notify me?
Where can I undergo screening?
Where does the screening test take place, and what does the doctor do?
Is screening pain-free?
From which age is screening recommended?
Who performs the screening?
How long does the screening test last?
Is screening risky, and can it cause any damage?
Intervention model program and its evaluation in Zala county
Socio-demographic characteristics of the study population from Zala county according to participation in cervical screening within three years
Participating in screening (n = 546)
Non-participating in screening (n = 88)
Household equivalent monthly income (Euro)
*p = 0.021
**p = 0.006
secondary education without final examination
secondary education with final examination
post-secondary education without diploma
college or university degree
As a result of the intervention model program 24 of the 88 women (27, 95%CI: 18–38%) participated in the screening program. Of the successful cases, there were 17 occasions in which a letter from the general practitioner was sufficient and 7 instances in which a personal conversation changed the mind of the participant.
Cervical cancer is a preventable cancer; evidence of the success of cytological screening is indicated by the low incidence of invasive cervical cancer in well-screened populations and by the high incidence and mortality in populations without screening . In 2013, the mortality rate was 6.02 per 100,000 women in Hungary. Based on the most recently available data, morbidity rates have declined over the past decades, with the mortality rate essentially remaining constant (5–6/100,000 women/year) since 2005 . Although the organized screenings began in 2003, the number of sample tests performed outside the program is still 20 times higher than the number performed within the screening program [7, 18]. According to our survey, the overall screening rate in Hungary (74%) is not low. The real frequency, however, is likely to be lower because of selection bias associated with a relatively low response rate of 47%. It is reasonable to assume that, on average, the level of health consciousness was higher among the respondents than that among the target population . GPs’ frequent contact with the public and their credibility offer a great potential for cancer prevention . Effective communication is a key success factor for an organized screening program . Our results showed that the majority of the target population did not receive any information about the screening program. Effective communication should be an inherent part of the screening program in order to enable the target population to make informed decisions about participation [20–22]. According to the results of our investigation, women asked for and received relevant information mainly from their gynecologists and characteristically not before screening but rather in the framework of the gynecological examination.
General practitioners had a very limited role in the cancer screening program in Hungary. The results obtained from the Zala county model project showed that the involvement of general practitioners in the cervical cancer screening program process could increase the participation of women who generally refuse these services. In the model program, a quarter of the women who typically did not take part in cervical cancer screening underwent the screening after advice from their general practitioner. Some recent developments in the Hungarian health care system have facilitated the participation of general practitioners in preventive activities. General practitioners gained online access to the records of their patients in the information system of the National Health Fund, and thus, they could obtain information about the type of outpatient and in-patient services their patients received, including screenings. Furthermore, the financing system for general practice, which still largely depends on capitation, was extended to performance-based financing [23, 24]. A small proportion of general practice fees currently depend on performance indicators. Participation of the target population in mammographic screening is already included in the list of indicators, but this is not yet the case for cervical cancer screening.
In developing a screening program, it is important to increase its accessibility, especially for low-income families and Romani people [25, 26]. Locally driven strategies that take into account the sociocultural beliefs and values of families can minimize barriers to cervical cancer prevention and control [27, 28]. If smears were taken in primary health care settings by GPs or nurses (as is standard practice in several Western European countries ), then participation rates in Hungary would probably increase. Primary health care services are more accessible to the general population. Staff are familiar with the cultural and socioeconomic background of the local population and could also be involved in local communication efforts regarding the program. It is important that the service utilization information is integrated with the screening information system. This is organized in Hungary in the framework of the cooperation between the National Health Insurance Fund and of the National Public Health Service. The recent development of the Hungarian e-health program, especially the establishment of the National Electronic Health Records, which centrally stores all medical records of every patient provides an opportunity for GPs themselves to follow-up their patients. To increase the accessibility of the cervical cancer screening program, the National Public Health Service has recently expanded the number of service providers. Health visitors were trained to take the smear and to provide the service locally, even in small villages. Smear taking has been integrated into the graduate training of health visitors, who traditionally provided only maternal and child care .
Pilot Health Visitor’s Cervical Screening Programs were introduced in 2009, and 15.8% (2009), 11.1% (2010) and 14.9% (2011) of the invited women appeared in each year for the request of the health visitors . The Health Visitor’s Cervical Screening Program was later institutionalized, and currently it operates as part of the national public health service. Its effectiveness can further be enhanced by the involvement of the GPs in health communication and motivation of the target population. Developing a community-based intervention that is evidence based and theoretically grounded is challenging and time intensive . It requires collaboration of different professionals, including medical and health professionals, psychologists, and sociologists.
Limitations of our study were the low response rate in the survey and the relatively small sample size in the intervention study. The main strength of our study was that it resulted in collaboration between primary care, the public health service and the cytology labs in one research project which served as a proof of concept to improve the screening program.
Our results reaffirm that the capacity of primary health services could be more efficiently utilized in preventive care in Hungary.
Community-oriented health services need to be reorganized. A new framework of cooperation is needed from the National Public Health Services, screening coordinators, general practitioners, nurses, health visitors and patients.
We would like to thank the general practitioners involved in the study.
The work was supported by a grant from the National Research and Development Program (NKFP-1/0003/2005).
Availability of data and materials
The data supporting the conclusions of this article are not available in a public repository, but can be available upon request from the corresponding author (ZV), in accordance with University of Debrecen research ethics policies.
AGY, AN, RÁ, VP and ZV conceptualized the study and led the design. AGY and ZV were involved in data analysis, presentation and interpretation of the results, and drafting the first and final version of the article. AN and DT were involved in data analysis, presentation and interpretation of the results. All authors critically revised the article for important intellectual content and approved the final draft.
Ethics approval and consent to participate
The study was approved by the ethical committee of the University of Debrecen [Regional and Institutional Ethics Committee, Clinical Centre, University Of Debrecen; number: 2698–2007]. All participants gave written informed consent to participate in the study.
VP is a full-time employee of GlaxoSmithKline Ltd., which has a financial interest related to the prevention of cervical cancer as the producer of a human papillomavirus vaccine. ZV regularly provided consultancy service for GlaxoSmithKline Hungary Ltd. as the member of its advisory board on vaccination and received funding for other research from the company.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- WHO European Health For All Database. http://www.euro.who.int/en/what-we-do/data-and-evidence/databases/european-health-for-all-database-hfa-db2/offline-version. Accessed 20 Feb 2017.Google Scholar
- Demographic Yearbook 2012. Budapest (HU): Hungarian Central Statistical Office; 2013.Google Scholar
- Döbrőssy L. Méhnyakrákszűrés 5 évtizede Magyarországon [Five decades of cervical cancer screening in Hungary]. Nőgyógyászati Onkológia. 2007;12:5–9. HungarianGoogle Scholar
- Kovács A, Döbrőssy L, Budai A, Boncz I, Cornides Á. A népegészségügyi méhnyakszűrés helyzete Magyarországon 2006-ban. [The state of organized cervical screening program in Hungary in 2006]. Orv Hetil. 2007;148(12):535–40.Google Scholar
- Országos Tisztifőorvosi Hivatal Méhnyakszűrési Munkacsoport: Lakossági méhnyakszűrés az „Egészség Évtizede” program keretében: törekvések a nőgyógyászati rákszűrés korszerűsítésére Magyarországon. [Working Group of Cervical Cancer Screening of National Chief Medical Officer’ Office: Mass screening of the uterine cervix in the program of the “Decade of Health”: perspectives of gynecologic cancer screening in Hungary.] Orv Hetil. 2004;145(1):35–40. [Hungarian]Google Scholar
- Boncz I, Sebestyén A, Ember I. Organized, nationwide cervical cancer screening programme in Hungary. Gynecol Oncol. 2007;106(1):272–3.View ArticlePubMedGoogle Scholar
- Kovács A, Döbrossy L, Budai A, Boncz I, Cornides A. Cervical screening in Hungary: why does the “English model” work but the “Hungarian model” does not? Eur J Gynaecol Oncol. 2008;29(1):5–9.PubMedGoogle Scholar
- Boncz I, Sebestyén A, Döbrőssy L, Kovács A, Budai A, Székely T. A méhnyakszűrés részvételi mutatói Magyarországon [The coverage of cervical screening in Hungary]. Orv Hetil. 2007;148(46):2177–82. HungarianView ArticlePubMedGoogle Scholar
- Kovács A, Boncz I. A szekunder prevenciós onkológiai szűrési programok helyzete Magyarországon. [the state of the organized oncological screening programs in Hungary]. Népegészségügy. 2009;87:265–75. HungarianGoogle Scholar
- Eurostat Database: Breast cancer and cervical cancer screenings [hlth_ps_scre] http://appsso.eurostat.ec.europa.eu/nui/show.do?dataset=hlth_ps_scre&lang=en Accessed 2 Jan 2018.
- Lofters AK, Schuler A, Slater M, Baxter NN, Persaud N, Pinto AD, et al. Using self-reported data on the social determinants of health in primary care to identify cancer screening disparities: opportunities and challenges BMC Family Practice. 2017; https://doi.org/10.1186/s12875-017-0599-z.
- Palència L, Espelt A, Rodríguez-Sanz M, Puigpinós R, Pons-Vigués M, Pasarín MI, et al. Socio-economic inequalities in breast and cervical cancer screening practices in Europe: influence of the type of screening program. Int J Epidemiol. 2010;39(3):757–65.View ArticlePubMedGoogle Scholar
- Gyulai A, Nagy A, Pataki V, Tonté D, Ádány R, Vokó Z. A survey of participation in an organised cervical cancer screening programme in Hungary. Cent Eur J Public Health. 2015;23(4):360–4.View ArticlePubMedGoogle Scholar
- Austoker J. Cancer prevention in primary care: screening for cervical cancer. BMJ. 1994;309(6949):241–8.View ArticlePubMedPubMed CentralGoogle Scholar
- Széles G, Vokó Z, Jenei T, Kardos L, Pocsai Z, Bajtay A, et al. A preliminary evaluation of a health monitoring programme in Hungary. Eur J Pub Health. 2005;15(1):26–32.View ArticleGoogle Scholar
- Stata Statistical Software Release 8.2 StataCorp LP, College Station, 2003; USA.Google Scholar
- Vesco KK, Whitlock EP, Eder M, Lin J, Burda BU, Senger CA, et al. Screening for cervical Cancer: a systematic evidence review for the U.S. preventive services task force. Evidence synthesis no. 86. AHRQ publication no. 11–05156- EF-1. Rockville: Agency for Healthcare Research and Quality; 2011.Google Scholar
- Anttila A, Ronco G. Working group on the registration and monitoring of cervical Cancer screening Programmes in the European Union; within the European network for information on Cancer (EUNICE). Description of the national situation of cervical cancer screening in the member states of the European Union. Eur J Cancer. 2009;45:2685–708.View ArticlePubMedGoogle Scholar
- McIlfatrick S, Keeney S, McKenna H, McCarley N, McElwee G. Investigating the role of the general practitioner in cancer prevention: a mixed methods study. BMC Fam Pract. 2013; https://doi.org/10.1186/1471-2296-14-58.
- Rimer BK, Briss PA, Zeller PK, Chan EC, Woolf SH. Informed decision making: what is its role in cancer screening? Cancer. 2004;101(5 Suppl):1214–28.View ArticlePubMedGoogle Scholar
- Giordano L, Webster P, Anthony C, Szarewski A, Davies P, Arbyn M, Segnan N, Austoker J. Improving the quality of communication in organised cervical cancer screening programmes. Patient Educ Couns. 2008;72(1):130–6.View ArticlePubMedGoogle Scholar
- Villani J, Mortensen K. Patient-provider communication and timely receipt of preventive services. Prev Med. 2013;57(5):658–63.View ArticlePubMedGoogle Scholar
- Kolozsvári LR, Rurik I. A háziorvosok teljesítményének minőségi értékelése. Mi a probléma a háziorvosi indikátorokkal? [evaluation of the quality of performance of general practitioners. What is the problem with primary care quality indicators in Hungary?]. Orv Hetil. 2016;157(9):328–35. HungarianGoogle Scholar
- Kolozsvári LR, Orozco-Beltran D, Rurik I. Do family physicians need more payment for working better? Financial incentives in primary care. Aten Primaria. 2014;46(5):261–6.View ArticlePubMedGoogle Scholar
- Baron RC, Rimer BK, Coates RJ, Kerner J, Mullen PD, Chattopadhyay S, Briss PA. Task force on community preventive services. Methods for conducting systematic reviews of evidence on effectiveness and economic efficiency of interventions to increase screening for breast, cervical, and colorectal cancers. Am J Prev Med. 2008;35(1S):26–33.View ArticleGoogle Scholar
- Spadea T, Bellini S, Kunst A, Stirbu I, Costa G. The impact of interventions to improve attendance in female cancer screening among lower socioeconomic groups: a review. Prev Med. 2010;50(4):159–64.View ArticlePubMedGoogle Scholar
- Bellinger JD, Millegan W, Abdalla AE. “I'm not ashamed to talk on it!”: African-American women's decisions about cervical cancer prevention and control in South Carolina. Womens Health. 2015;25(2):120–7.Google Scholar
- Crawford J, Ahmad F, Beaton D, Bierman AS. Cancer screening behaviours among south Asian immigrants in the UK, US and Canada: a scoping study. HSCC. 2016;24(2):123–53.Google Scholar
- Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N, et al. European Guidelines for Quality Assurance in Cervical Cancer Screening. 2nd ed. Luxembourg (LU): Office for Official Publications of the European Communities; 2008.Google Scholar
- Döbrőssy L, Kovács A, Budai A, Odor A, Fehér E. Screening for cervical cancer in Hungary: new role for health visitors. Clin Nurs Stud. 2013;1(3):32–8.Google Scholar
- Fehér E. A Védőnői Méhnyakszűrő Programok 3 éve [3 years of Health Visitor ‘s Cevical Screening Programs]. Védőnő. 2012;12(2):5–9. HungarianGoogle Scholar
- Smith JL, Wilson KM, Orians CE, Byrd TL. AMIGAS: building a cervical cancer screening intervention for public health practice. J Womens Health. 2013;22(9):718–23.View ArticleGoogle Scholar